Neuronetics STIM Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Clinical Services | $21.53M+15.4% | —— | —— | —— | $18.66M+1,579% | |
| Medical Device | $12.93M-2.9% | —— | $37.3M+101% | $38.11M+132% | $13.32M-23.5% | |
| Revenue by Product | ||||||
| Clinic Revenue | $21.53M+15.4% | $23.49M+2,013% | $21.81M+1,862% | $23.02M+1,972% | $18.66M+1,579% | |
| Neuro Star Advanced Therapy System | $3.25M+7.9% | $4.92M+18.0% | $3.96M-9.1% | $3.65M-8.9% | $3.01M-15.6% | |
| Service | $21.53M+15.4% | —— | —— | —— | $18.66M+1,579% | |
| Treatment Sessions | $9.25M-5.3% | $12.84M-1.8% | $10.76M-19.8% | $11.05M-6.3% | $9.76M-25.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Neuronetics break its business down?
- Neuronetics (STIM) reports revenue by business across 2 parts — Clinical Services and Medical Device. Each is extracted from the segment footnotes and tracked over time.
- Where does Neuronetics's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Neuronetics's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
